Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Cancer Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03926936
What this trial is testing

FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study

Who this might be right for
Endometrial Stromal SarcomaAdenosarcoma of UterusLeiomyosarcoma Uterus+3 more
Frederic Amant 17
Testing effectiveness (Phase 2)Study completedNCT03276013
What this trial is testing

Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Vall d'Hebron Institute of Oncology 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05761951
What this trial is testing

Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT02730429
What this trial is testing

Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 78
Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Looking for participantsNCT05797831
What this trial is testing

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Kartos Therapeutics, Inc. 268
Testing effectiveness (Phase 2)Looking for participantsNCT05559879
What this trial is testing

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Who this might be right for
Gynecologic CancerCarcinomaUterine Cancer+1 more
University of Alabama at Birmingham 37
Testing effectiveness (Phase 2)Study completedNCT01367002
What this trial is testing

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

Who this might be right for
Endometrial Cancer
Yale University 61
Testing effectiveness (Phase 2)Study completedNCT00087685
What this trial is testing

RAD001 in Recurrent Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00064025
What this trial is testing

Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation+5 more
Gynecologic Oncology Group 75
Testing effectiveness (Phase 2)Study completedNCT02755844
What this trial is testing

Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients

Who this might be right for
Recurrent Endometrial Cancer
Hospices Civils de Lyon 35
Early research (Phase 1)Looking for participantsNCT06795009
What this trial is testing

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Who this might be right for
Uterine CancerEndometrial Cancer
Washington University School of Medicine 36
Testing effectiveness (Phase 2)Looking for participantsNCT07209449
What this trial is testing

Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT00071929
What this trial is testing

Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT04814108
What this trial is testing

Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma

Who this might be right for
Uterine Serous Carcinoma
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 92
Testing effectiveness (Phase 2)Study completedNCT02725268
What this trial is testing

Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Millennium Pharmaceuticals, Inc. 241
Testing effectiveness (Phase 2)Study completedNCT00027690
What this trial is testing

Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus Carcinoma
National Cancer Institute (NCI) 56
Early research (Phase 1)Active Not RecruitingNCT03120624
What this trial is testing

VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer

Who this might be right for
Metastatic Endometrial CarcinomaRecurrent Endometrial AdenocarcinomaRecurrent Endometrial Carcinoma+7 more
Mayo Clinic 34
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Not applicableUnknownNCT01150682
What this trial is testing

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group 865
Next Page